The once-high-flying firm has been beset by challenges since going public via a SPAC merger in 2021. Here’s the latest.

Earlier this year, three Welly locals decided their limited running experience and lack of interest in PBs shouldn't hold ...

No. 23andMe is considered a direct-to-consumer genetic testing company, and transactions with the company are considered commercial, not medical. Because 23andMe is not a medical company, customers' ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

Life Kit is here to help you get it together. Want another life hack? Try Life Kit+. You'll support the show and unlock exclusive curated playlists and sponsor-free listening. Learn more at plus ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The CEO of 23andMe said there was "substantial doubt" that the company could continue to operate and said 40 percent of its ...

Me, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business challenges, ...

Shares of 23andMe Holding Co. fell 4% Tuesday after the DNA-testing company reported its latest quarterly loss and included “going concern” language in its financial statements, shedding gains made ...